Solara Active Pharma Sciences Limited

Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated October 16, 2026, titled "Solara s Q2 FY27 revenue grows 33% to INR 4,178 Mn and EBITDA more than doubles to INR 769 Mn, its best quarter in five years".

Solara Active Pharma Sciences Limited has informed the Exchange regarding allotment of 8,300 equity shares pursuant to exercise of ESOP options.

Solara Active Pharma Sciences Limited has informed the exchange regarding inter alia, to consider and approve the unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026, along with the Limited Review Report for the said period.

EID Parry India Ltd - 500125 - Disclosure Of ESG Ratings

Modison Ltd-$ - 506261 - Corporate Action-Board approves Dividend